Trending...
- Perricone Hydrogen Water: The Powerful Science-Backed Breakthrough in Anti-Inflammatory & Anti-Aging
Kevin Cordell joins Andy Reid and Trey Moore to lead seed fund targeting transformative HealthTech, MedTech, and AI companies.
GREENWICH, Conn. - Hartok -- Mission 3A HealthTech Venture Fund, an early stage seed fund dedicated to backing transformative HealthTech and AI-driven companies, is proud to announce that Kevin Cordell has joined the firm as a Managing Partner. He will lead the fund alongside Andy Reid and Trey Moore, leveraging their combined track record of generating a 25x return across seven prior healthtech venture investments.
Kevin brings extensive leadership and commercialization expertise to Mission 3A. He most notably served as a key executive in Wright Medical's $5.4 billion strategic exit to Stryker. Throughout his career, he has focused on scaling global businesses, identifying breakthrough technologies early, and driving commercial strategies—experience that will help Mission 3A's portfolio companies accelerate growth and navigate the complex healthcare landscape.
"I'm thrilled to join Mission 3A HealthTech Venture Fund at a time when healthcare is undergoing a transformational shift," said Kevin Cordell, Managing Partner. "This fund is uniquely positioned to identify and accelerate the AI and MedTech companies that will redefine patient care. I'm excited to work alongside Andy and Trey to help founders move faster, scale smarter, and achieve game-changing outcomes."
More on hartok.com
Mission 3A HealthTech Venture Fund was founded to identify and back the next generation of HealthTech and AI leaders, said Andy Reid, Managing Partner. "Kevin's experience in driving some of the most significant growth stories in MedTech makes him an invaluable addition as we continue to build and back category-defining companies."
Trey Moore, Managing Partner, added: "Kevin's ability to recognize market-shifting products and companies is unmatched. Combined with Andy's deep commercial execution and my entrepreneurial track record—including co-founding AirStrip and Splice—our team offers an unparalleled platform for HealthTech founders."
About: Mission 3A HealthTech Venture Fund invests in early-stage companies across MedTech, SaaS, and AI-driven healthcare. By leveraging its extensive network of surgeons, ASCs, hospital executives, and distribution partners, the fund accelerates adoption and drives value creation. Mission 3A HealthTech Venture Fund is targeting its final close in Q4 2025 and is positioned to deliver outsized returns by backing the most promising technologies reshaping the healthcare industry.
Kevin brings extensive leadership and commercialization expertise to Mission 3A. He most notably served as a key executive in Wright Medical's $5.4 billion strategic exit to Stryker. Throughout his career, he has focused on scaling global businesses, identifying breakthrough technologies early, and driving commercial strategies—experience that will help Mission 3A's portfolio companies accelerate growth and navigate the complex healthcare landscape.
"I'm thrilled to join Mission 3A HealthTech Venture Fund at a time when healthcare is undergoing a transformational shift," said Kevin Cordell, Managing Partner. "This fund is uniquely positioned to identify and accelerate the AI and MedTech companies that will redefine patient care. I'm excited to work alongside Andy and Trey to help founders move faster, scale smarter, and achieve game-changing outcomes."
More on hartok.com
- Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
- NovoSculpt Redefines Body Contouring Standards with Patent-Pending Technology in Cos Cob, CT
- America's Premier Carrera GT Specialist Unveils New Digital Experience
- "Willingness" Without Authority: Boeing's AS9100 Rhetoric Collapses Under Scrutiny
- Connecticut Entrepreneur and Author Justin Calabrese Raises Awareness of Abuse
Mission 3A HealthTech Venture Fund was founded to identify and back the next generation of HealthTech and AI leaders, said Andy Reid, Managing Partner. "Kevin's experience in driving some of the most significant growth stories in MedTech makes him an invaluable addition as we continue to build and back category-defining companies."
Trey Moore, Managing Partner, added: "Kevin's ability to recognize market-shifting products and companies is unmatched. Combined with Andy's deep commercial execution and my entrepreneurial track record—including co-founding AirStrip and Splice—our team offers an unparalleled platform for HealthTech founders."
About: Mission 3A HealthTech Venture Fund invests in early-stage companies across MedTech, SaaS, and AI-driven healthcare. By leveraging its extensive network of surgeons, ASCs, hospital executives, and distribution partners, the fund accelerates adoption and drives value creation. Mission 3A HealthTech Venture Fund is targeting its final close in Q4 2025 and is positioned to deliver outsized returns by backing the most promising technologies reshaping the healthcare industry.
Source: Mission 3A HealthTech Venture Fund
0 Comments